Cost-Utility Analysis (cua) Of First-Line Disease-Modifying Treatments (DMT) Versus Best Supportive Care (Bsc) In Finnish Relapsing-Remitting Multiple Sclerosis (RRMS) Patients
2014 ◽
Vol 17
(7)
◽
pp. A399
◽
E. Soini
◽
C. Asseburg
◽
M.L. Sumelahti
2013 ◽
Vol 16
(7)
◽
pp. A624
A. Imani
◽
M. Golestani
◽
J.S. Tabrizi
◽
A. Janati
2000 ◽
Vol 3
(5)
◽
pp. 362-363
E Orlewska
◽
P Mierzejewski
◽
A Czlonkowska
2016 ◽
Vol 19
(7)
◽
pp. A434
◽
J Ordóñez
◽
P Serafini
◽
M Machado
2003 ◽
Vol 6
(3)
◽
pp. 277
C Rubio-Terrés
◽
F Medina
◽
I Aristegui
◽
G Izquierdo
2016 ◽
Vol 19
(3)
◽
pp. A61
L Fahham
◽
L Murta
◽
V Teich
◽
M Machado
◽
P Serafini
C. Lazzaro
◽
R. Bergamaschi
◽
M. Zaffaroni
◽
R. Totaro
◽
D. Paolicelli
2016 ◽
Vol 19
(3)
◽
pp. A63
◽
2017 ◽
Vol 39
(3)
◽
pp. 537-557.e10
◽
Erkki Soini
◽
Jaana Joutseno
◽
Marja-Liisa Sumelahti
2015 ◽
Vol 18
(7)
◽
pp. A758
◽
L Silva Miguel
◽
J de Sá
◽
B Pinheiro
◽
C Acosta
2018 ◽
Vol 22
(3)
◽
pp. 226-237
◽
Evelyn Walter
◽
Thomas Berger
◽
Barbara Bajer-Kornek
◽
Florian Deisenhammer
Close
Export Citation Format
Close
Share Document
Close